Australian patient travels 9,000 miles for a cure

March 7, 2019 | Michael Easterling

Australian lobster fisherman David Thompson traveled 9,000 miles for treatment at City of Hope after being diagnosed with Stage 4 oropharyngeal cancer. Given just six weeks to live, he is thriving more than a year after participating in an immunotherapy clinical trial.

Continue Reading

Patient diversity not reflected by cell lines used for research, study shows

March 13, 2019 | Zen Vuong

City of Hope scientist, Rick Kittles, Ph.D., and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.

‘Watch-and-wait’ approach for low-risk prostate cancer not without dangers

March 7, 2019 | Malcolm Bedell

Men diagnosed with “low-risk” prostate cancer are increasingly refusing more aggressive treatment in favor of a watch-and-wait approach. However, determining which patients truly fall into the “low-risk” category can prove more complicated than some tests would make it seem.

Study finds cancer rate rising in millennials

March 6, 2019 | Dory Benford

A new study by the American Cancer Society finds rates of obesity-related cancers — including colorectal, endometrial, pancreatic, kidney, gallbladder and multiple myeloma — rising among young people.

First Cancer Linked to Gluteal Implants Described

March 4, 2019 | Samantha Bonar

In the first reported case of its kind, gluteal implants have been linked to a rare form of cancer that ultimately led to a woman’s death.

Finding better treatments for devastating rare diseases

February 27, 2019 | Abe Rosenberg

City of Hope has long been renowned for its expertise in treating cancer and diabetes. But specialists here also are tackling lesser-known but equally devastating diseases that may or may not have an oncologic component.

City of Hope earns third prestigious Lymphoma SPORE Grant from NCI

February 26, 2019 | Letisia Marquez

City of Hope has earned its third Lymphoma Specialized Programs of Research Excellence grant from the National Cancer Institute, which provides $12.5 million for research.

Study explores why glioblastoma affects sexes differently

February 25, 2019 | City of Hope

A nationwide team of researchers that includes City of Hope’s Translational Genomics Research Institute (TGen) has identified molecular differences that explain why men die of glioblastoma, a type of brain cancer, at nearly twice the rate of women.

Study by diabetes expert describes promising type 1 treatments

February 14, 2019 | Katie Neith

A paper co-authored by Bart Roep, Ph.D., Chan Soon-Shiong Shapiro Distinguished Chair in Diabetes and the founding chair of the Department of Diabetes Immunology at City of Hope, published in Nature explores new ways of replacing beta cells after too many of them have been killed by the immune system.

Vanessa Jonsson, Ph.D.: An engineer tackles CAR T cell therapy

February 13, 2019 | City of Hope

Vanessa Jonsson, Ph.D., focuses on chimeric antigen receptor (CAR) T cell therapy. Using such tools as computational analysis and mathematical modeling, she examines the complex interactions between the tumor, the patient’s immune system and the therapy to learn how the tumor evades the immune response.

The science of second opinions: Advice from a surgeon

February 13, 2019 | City of Hope

Diagnostic errors are far from uncommon. In fact, one recent study found that they affect about 12 million people, or 1 in 20 patients, in the U.S. each year. Clayton Lau, M.D., explains the difference that second opinions can make in getting proper cancer diagnosis and care.